Preliminary Experience With the Xtrak Debulking Device in the Treatment of Peripheral Occlusions

Abstract

These initial results demonstrate that the Xtrak device can safely debulk long segments of diffusely diseased arteries in a single pass while simultaneously retrieving the occluding material. Supplementary angioplasty may be required in the majority of cases. Larger studies are required to determine whether debulking followed by balloon dilation improves the long-term prognosis in patients with chronic lower limb occlusions.

Two-Year Results after Directional Atherectomy of Infrapopliteal Arteries with the SilverHawk Device

“…DA may be an alternative tool to reduce the restenosis rate without implanting a device such as a stent. However, previous devices were limited to vessel diameters of at least 4 mm, [21][22][23][24][25][26][27][28][29] and the smaller diameter Silver-Hawk device made it feasible to treat vessels with diameters of minimum 2.0 mm. Acute and midterm technical results using this device were encouraging.…”

Initial Clinical Experience with Percutaneous Atherectomy in the Infragenicular Arteries

“…However, the application of atherectomy devices has been limited to vessels with diameters of at least 4 mm. [8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23] Even a new, recently tested 7-F atherectomy device proved incompatible with vessels Ͻ4 mm. 24 Added to this size limitation of directional atherectomy are the technical deficiencies seen when the Simpson Atherocath was used in pelvic and femoropopliteal arteries.…”

Infrainguinal Arterial Intervention: Is There a Role for an Atherectomy Device?

“…29 Additional devices, such as the Bard Rotary Atherectomy System (BRAS) (CR Bard, Murray Hill, NJ), the rotoblator Boston Scientific, Natick, MA) and the Xtrak device (Xtrak Medical Inc, Salem, NH), have also been evaluated in the periphery, have shown poor results, have been met with limited clinical enthusiasm, and have no significant current clinical use. [30][31][32] …”